Search for: "WATSON PHARMACEUTICALS "
Results 341 - 359
of 359
Sorted by Relevance
|
Sort by Date
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
6 Oct 2021, 2:01 pm
Note: The following is the testimony of Dr. [read post]
2 Jan 2016, 2:51 pm
Next week, the 110th AALS Annual Meeting starts in New York. [read post]
6 Apr 2017, 1:35 pm
The initial text of the decision in The Medicines Company v. [read post]
23 Jan 2017, 1:25 am
The CJEU’s recent decision in the Tele2/Watson case may call the viability of the new Investigatory Powers Act into question. [read post]
1 Sep 2011, 5:10 pm
As Justice Kennedy puts it: “the State defends the law by insisting that “pharmaceutical marketing has a strong influence on doctors’ prescribing practices. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
24 Jun 2011, 1:24 pm
[Readers: Set forth below is a thoughtful and detailed analysis of the Supreme Court's decision of Walmart v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
1 Mar 2007, 4:57 am
The third generation oral contraceptives containing desogestrel are:Desogestrel and Ethinyl Estradiol (Duramed/Barr and Watson Pharmaceuticals)Desogen (Organon)Mircette (Duramed/Barr)Velivet (Duramed)Apri-28 (Duramed/Barr)Kariva (Duramed/Barr)Ortho-Cept (Ortho-McNeil)Reclipsen (Watson)Cyclessa (Organon)It is estimated that women in the U.S. filled more than 7.5 million prescriptions for third generation oral contraceptives this past year (November 2005 to October 2006)… [read post]
21 Jun 2019, 3:00 am
Legal Fight Tougher for Congressman as Wife Pleads Guilty AP News – Julie Watson | Published: 6/13/2019 Indicted U.S. [read post]
13 Jan 2011, 2:52 pm
., provides for safe disposal of controlled substances, including dangerous pharmaceuticals that can hurt wildlife when they are dumped in the trash or flushed away, and end up in the environment. [read post]
18 May 2009, 5:24 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: China and UK to fast track green patent applications, according to British IP minister (IAM) (IPKat) (Intellectual Property Watch) Golan case may put US in violation of international copyright treaties (Intellectual Property Watch) Taylor Wessing releases Global IP Index 2009 (IP Think Tank) (Managing Intellectual Property) (IP Dragon) (IAM)… [read post]
3 May 2022, 1:55 am
Key Findings Federal policymakers are debating a legislative package focused on boosting U.S. competitiveness vis-a-vis China; however, it currently contains little to no improvements to the U.S. tax code. [read post]
27 Jan 2012, 2:21 pm
A. [read post]
29 Aug 2022, 9:05 pm
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]
24 Mar 2010, 11:33 am
Ariad Pharmaceuticals et al v. [read post]
5 Aug 2010, 2:08 pm
When the Levine, Riegel, and Kent cases were briefed in the United States Supreme Court, we provided our readers with “users’ guides”/”guided tours” that summarized the defense side arguments and pointed out whatever we thought was interesting.Today we’re continuing that tradition with the Bruesewitz (sooner or later we’ll memorize how to spell that) v. [read post]
